InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the detailed record of transactions filed by Knutson Gregory, Director. Director active across 1 companies, notably U.S. Stem Cell, Inc.. Cumulatively, 4 disclosures have been logged. The latest transaction was disclosed on 25 April 2022 — Attribution. Regulator: SEC (Form 4). The full history is openly available.
Declarations4 total
€9,3332,500,000 shares@ €0.003714.55% mcap4.5% of flow
Common Stock
SEC:0001185185-22-000518:0·
€180,18825,000,000 shares@ €0.007287.7% of flow
Common Stock
SEC:0001185185-22-000329:0·
€7,9191,445,647 shares@ €0.0055100.0% of flow
Common Stock
SEC:0001185185-21-001026·
€7,9191,445,647 shares@ €0.005512.34% mcap3.9% of flow
Common Stock
SEC:0001185185-21-001026:0·
4 of 4 declarations
About Knutson Gregory
Knutson Gregory is a Director at U.S. Stem Cell, Inc. As a board member, he contributes to the governance and strategy of the company. His experience in the biotechnology sector allows him to provide valuable strategic insights. Gregory is committed to supporting the company's mission and fostering its growth.
